Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra D Jensen

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2015
Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapyAlexandra D Jensen, Melanie Poulakis, Anna V Nikoghosyan, et al.
BMC Cancer|May 21, 2011
Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HITAlexandra D Jensen, Jürgen Krauss, Karin Potthoff, et al.
BMC Cancer|December 21, 2007
Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocolNathalie Rochet, Alexandra D Jensen, Florian Sterzing, et al.
BMC Cancer|November 27, 2010
Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocolGregor Habl, Alexandra D Jensen, Karin Potthoff, et al.
Cancer|February 7, 2014
High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term resultsMatthias Uhl, Matthias Mattke, Thomas Welzel, et al.
Cancer|January 26, 2011
Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trialAlexandra D Jensen, Marc W Münter, Helge G Bischoff, et al.
Frontiers in Oncology|December 30, 2021
<i>In Silico</i> Feasibility Study of Carbon Ion Radiotherapy With Simultaneous Integrated Boost for Head and Neck Adenoid Cystic CarcinomaEdoardo Mastella, Silvia Molinelli, Giuseppe Magro, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2011
Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PCAnna V Nikoghosyan, Daniela Schulz-Ertner, Klaus Herfarth, et al.
Radiation Oncology (London, England)|June 16, 2017
Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective studyEvelyn Herrmann, Nando Mertineit, Berardino De Bari, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2009
Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I studyNathalie Rochet, Florian Sterzing, Alexandra D Jensen, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2015
Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapyAlexandra D Jensen, Melanie Poulakis, Anna V Nikoghosyan, et al.
BMC Cancer|May 21, 2011
Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HITAlexandra D Jensen, Jürgen Krauss, Karin Potthoff, et al.
BMC Cancer|December 21, 2007
Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocolNathalie Rochet, Alexandra D Jensen, Florian Sterzing, et al.
BMC Cancer|November 27, 2010
Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocolGregor Habl, Alexandra D Jensen, Karin Potthoff, et al.
Cancer|February 7, 2014
High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term resultsMatthias Uhl, Matthias Mattke, Thomas Welzel, et al.
Cancer|January 26, 2011
Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trialAlexandra D Jensen, Marc W Münter, Helge G Bischoff, et al.
Frontiers in Oncology|December 30, 2021
<i>In Silico</i> Feasibility Study of Carbon Ion Radiotherapy With Simultaneous Integrated Boost for Head and Neck Adenoid Cystic CarcinomaEdoardo Mastella, Silvia Molinelli, Giuseppe Magro, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2011
Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PCAnna V Nikoghosyan, Daniela Schulz-Ertner, Klaus Herfarth, et al.
Radiation Oncology (London, England)|June 16, 2017
Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective studyEvelyn Herrmann, Nando Mertineit, Berardino De Bari, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2009
Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I studyNathalie Rochet, Florian Sterzing, Alexandra D Jensen, et al.
Pageof 5